Edges in Network
| Network | GSE25066_egf1520 - GSE25066 - SiGN-BN HC+Bootstrap |
| Network Description | Genomic predictor of response and survival following neoadjuvant taxane-anthracycline chemotherapy in breast cancer |
| Node | HSD17B2 |
| Upstream (Parents) |
|---|
| (<<) ADCY9 → HSD17B2 |
| (<<) CBFA2T3 → HSD17B2 |
| (<<) CDH3 → HSD17B2 |
| (<<) CEBPB → HSD17B2 |
| (<<) CHI3L1 → HSD17B2 |
| (<<) CHST3 → HSD17B2 |
| (<<) CRYAB → HSD17B2 |
| (<<) CSTB → HSD17B2 |
| (<<) CXCL2 → HSD17B2 |
| (<<) CXCR7 → HSD17B2 |
| (<<) CYP1B1 → HSD17B2 |
| (<<) EGFR → HSD17B2 |
| (<<) ELF5 → HSD17B2 |
| (<<) ENO1 → HSD17B2 |
| (<<) FZD7 → HSD17B2 |
| (<<) GDF15 → HSD17B2 |
| (<<) HIF1A → HSD17B2 |
| (<<) IDI1 → HSD17B2 |
| (<<) KLK5 → HSD17B2 |
| (<<) KRT5 → HSD17B2 |
| (<<) MLPH → HSD17B2 |
| (<<) NFIB → HSD17B2 |
| (<<) PHGDH → HSD17B2 |
| (<<) PRKAB1 → HSD17B2 |
| (<<) PSAT1 → HSD17B2 |
| (<<) PTK7 → HSD17B2 |
| (<<) RBM7 → HSD17B2 |
| (<<) RRAS2 → HSD17B2 |
| (<<) SLPI → HSD17B2 |
| (<<) SOX9 → HSD17B2 |
| (<<) TFF1 → HSD17B2 |
| (<<) UAP1 → HSD17B2 |
| (<<) UBE2E3 → HSD17B2 |
| (<<) WWTR1 → HSD17B2 |
| Downstream (Children) |
|---|
| HSD17B2 → ALOX15B (>>) |
| HSD17B2 → DRD4 (>>) |
| HSD17B2 → EDN1 (>>) |
| HSD17B2 → ENO2 (>>) |
| HSD17B2 → FA2H (>>) |
| HSD17B2 → FZD8 (>>) |
| HSD17B2 → HKDC1 (>>) |
| HSD17B2 → IGFBP2 (>>) |
| HSD17B2 → MPHOSPH6 (>>) |
| HSD17B2 → MRAS (>>) |
| HSD17B2 → ORM1 (>>) |
| HSD17B2 → PPP1R12B (>>) |
| HSD17B2 → SPRR1A (>>) |
| HSD17B2 → SPRR3 (>>) |
| HSD17B2 → TGFB2 (>>) |
| HSD17B2 → TNFRSF11A (>>) |
| HSD17B2 → WNT5A (>>) |
| HSD17B2 → ZNF750 (>>) |
